Analyst Ratings for Centessa Pharmaceuticals (CNTA)
CNTA Rating Summary
CNTA Price Target Summary
- Highest: $62.00 (Oppenheimer)
- Lowest: $36.00 (Morgan Stanley)
- Average: $43.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$43.00 (+7.4%)
* Over Last 12-Mos
Rating Score: 4.7 / 10
Percentile Rank: 47%
Avg. $ Target:
$43.00 (+7.4%)
* Over Last 12-Mos
Rating Score: 4.7 / 10
Percentile Rank: 47%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/20/2026 | Wells Fargo | Benjamin Burnett | Downgrade | Equal Weight (Overweight) |
42.00 (35.00) |
39.66 (40.02) |
0.91% | Details |
| 4/13/2026 | Truist Securities | Danielle Brill | Downgrade | Hold (Buy) |
38.00 (N/A) |
39.76 (40.02) |
0.65% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
